rs74315364
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_021133.4(RNASEL):c.793G>T(p.Glu265*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00369 in 1,614,092 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_021133.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- prostate cancer, hereditary, 1Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021133.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RNASEL | TSL:1 MANE Select | c.793G>T | p.Glu265* | stop_gained | Exon 2 of 7 | ENSP00000356530.3 | Q05823-1 | ||
| RNASEL | c.793G>T | p.Glu265* | stop_gained | Exon 2 of 7 | ENSP00000616605.1 | ||||
| RNASEL | c.793G>T | p.Glu265* | stop_gained | Exon 2 of 7 | ENSP00000560918.1 |
Frequencies
GnomAD3 genomes AF: 0.00325 AC: 495AN: 152184Hom.: 3 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00362 AC: 901AN: 249190 AF XY: 0.00377 show subpopulations
GnomAD4 exome AF: 0.00373 AC: 5453AN: 1461790Hom.: 16 Cov.: 35 AF XY: 0.00374 AC XY: 2722AN XY: 727196 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00326 AC: 496AN: 152302Hom.: 3 Cov.: 32 AF XY: 0.00314 AC XY: 234AN XY: 74468 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at